Mediterranean diet in the Castilian plains: Dietary patterns and childhood asthma in 6-7-year-old children from the province of Salamanca.

Salamanca is the only Spanish center with no coastal line participating in the Global Asthma Network phase-I study. Questionnaires were collected from 6-7-year-old 2388 children and analyzed in particular for their diet and asthma symptoms as part of this study. The prevalence of current asthma (CA) was 9%, doctor-confirmed asthma (DCA) was 7%, and current severe asthma (CSA) accounted to 2.9%. Two Mediterranean Diet Scores (MDS) were performed to evaluate adherence of these children to the Mediterranean diet. Principal component analysis generated four dietary patterns. The relationship between asthma and each food type, MDS, and dietary patterns was assessed using multivariate adjusted logistic regression. Adherence to the Mediterranean diet by Salamanca's children and prevalence of asthma in Salamanca were similar to the findings of coastal located centers of other studies. High punctuation in MDS was associated with high prevalence of asthma. Higher scores for the pattern "Fats and sugar" was associated with less current asthma but not with DCA or CSA. These findings might be due to improvement in the diet of asthma children, reverse causation factor, how the questionnaire collected information about diet, and perhaps the manner in which the scores were constructed. The complexity of interconnections between nutrients, foods, and dietary patterns, and the heterogeneous nature of asthma, makes it difficult to identify single factor that affected its development. Our findings require corroboration by additional studies.

GEMA 5.3. Spanish Guideline on the Management of Asthma.

The Spanish Guideline on the Management of Asthma, better known by its acronym in Spanish GEMA, has been available for more than 20 years. Twenty-one scientific societies or related groups both from Spain and internationally have participated in the preparation and development of the updated edition of GEMA, which in fact has been currently positioned as the reference guide on asthma in the Spanish language worldwide. Its objective is to prevent and improve the clinical situation of people with asthma by increasing the knowledge of healthcare professionals involved in their care. Its purpose is to convert scientific evidence into simple and easy-to-follow practical recommendations. Therefore, it is not a monograph that brings together all the scientific knowledge about the disease, but rather a brief document with the essentials, designed to be applied quickly in routine clinical practice. The guidelines are necessarily multidisciplinary, developed to be useful and an indispensable tool for physicians of different specialties, as well as nurses and pharmacists. Probably the most outstanding aspects of the guide are the recommendations to: establish the diagnosis of asthma using a sequential algorithm based on objective diagnostic tests; the follow-up of patients, preferably based on the strategy of achieving and maintaining control of the disease; treatment according to the level of severity of asthma, using six steps from least to greatest need of pharmaceutical drugs, and the treatment algorithm for the indication of biologics in patients with severe uncontrolled asthma based on phenotypes. And now, in addition to that, there is a novelty for easy use and follow-up through a computer application based on the chatbot-type conversational artificial intelligence (ia-GEMA).

La Guía Española para el Manejo del Asma, mejor conocida por su acrónimo en español, GEMA, está a nuestra disposición desde hace más de veinte años. Veintiuna sociedades científicas o grupos relacionados, tanto de España como de otros países, han participado en la preparación y desarrollo de la edición actualizada de GEMA que, de hecho, se ha posicionado en la actualidad a nivel mundial como la guía de referencia sobre asma en lengua española.Su objetivo es prevenir y mejorar la situación clínica de las personas con asma, aumentando el conocimiento de los profesionales sanitarios involucrados en su cuidado. Su propósito es convertir la evidencia científica en recomendaciones prácticas sencillas y fáciles de seguir. Por lo tanto, no se trata de una monografía que reúna todo el conocimiento científico sobre la enfermedad, sino más bien de un documento conciso con lo esencial, diseñado para ser aplicado rápidamente en la práctica clínica de rutina. Las recomendaciones son necesariamente multidisciplinares, están desarrolladas para ser útiles y una herramienta indispensable para médicos de diferentes especialidades, así como para profesionales de enfermería y farmacia.Seguramente, los aspectos más destacados de la guía son las recomendaciones para: establecer el diagnóstico del asma utilizando un algoritmo secuencial basado en pruebas diagnósticas objetivas; el seguimiento de los pacientes, preferentemente basado en la estrategia de lograr y mantener el control de la enfermedad; el tratamiento según el nivel de gravedad del asma utilizando seis escalones, desde la menor hasta la mayor necesidad de medicamentos, y el algoritmo de tratamiento basado en fenotipos para la indicación de biológicos en pacientes con asma grave no controlada. A esto se suma ahora una novedad para su fácil uso y seguimiento a través de una aplicación informática basada en la inteligencia artificial conversacional de tipo chatbot (ia-GEMA).

Prevalence and temporal evolution of asthma symptoms in Spain. Global Asthma Network (GAN) study.

INTRODUCTION: The temporal evolution of the prevalence of asthma described in the ISAAC (International Study of Asthma and Allergies in Childhood) in 2002 is unknown, or if the geographical or age differences are maintained in Spain. OBJECTIVE: To describe the prevalence of asthma symptoms in different Spanish geographic areas and compare it with that of those centers that participated in the ISAAC. METHODS: Cross-sectional study of asthma prevalence, carried out in 2016-2019 with 19,943 adolescents aged 13-14 years and 17,215 schoolchildren aged 6-7 years from 6 Spanish geographical areas (Cartagena, Bilbao, Cantabria, La Coruña, Pamplona and Salamanca). Asthma symptoms were collected using a written questionnaire and video questionnaire according to the Global Asthma Network (GAN) protocol. RESULTS: The prevalence of recent wheezing (last 12 months) was 15.3% at 13-14 years and 10.4% at 6-7 years, with variations in adolescents, from 19% in Bilbao to 10.2% in Cartagena; and in schoolchildren, from 11.7% in Cartagena to 7% in Pamplona. These prevalences were higher than those of the ISAAC (10.6% in adolescents and 9.9% in schoolchildren). 21.3% of adolescents and 12.4% of schoolchildren reported asthma at some time. CONCLUSIONS: There is a high prevalence of asthmatic symptoms with an increase in adolescents and a stabilization in Spanish schoolchildren with respect to the ISAAC. Geographic variations in asthma prevalence are not so clearly appreciated, but areas with high prevalences maintain high numbers.

Prevalence and time trends of symptoms of allergic rhinitis and rhinoconjunctivitis in Spanish children: Global Asthma Network (GAN) study

Introduction: The time trends of the prevalence of rhinitis, rhinoconjunctivitis and nasal allergy previously described in the ISAAC (International Study of Asthma and Allergies in Childhood) in 2002 are unknown; or if the geographical or age differences in Spain persist. Objective: To describe the prevalence of rhinitis, rhinoconjunctivitis and nasal allergy in different Spanish geographical areas and compare them with those of the ISAAC. Methods: Cross-sectional study of the prevalence of rhinitis, rhinoconjunctivitis and nasal allergy, carried out in 2016-2019 on 19943 adolescents aged 13-14 years and 17215 schoolchildren aged 6-7 years from six Spanish areas (Cartagena, Bilbao, Cantabria, La Coruña, Pamplona, and Salamanca), through a questionnaire based on the Global Asthma Network (GAN) protocol. Results: The prevalences of recent rhinitis and rhinoconjunctivitis (last 12 months), and nasal allergy/hay fever were 35.1%, 17.6%, and 14.6% in the adolescents and 20%, 8.5%, and 8.9% in the schoolchildren, respectively, with rhinoconjunctivitis in adolescents varying from 20.9% in Bilbao to 13.4% in Cartagena; and in schoolchildren, from 9.8% in La Coruña to 6.4% in Pamplona. These prevalences of rhinoconjunctivitis and nasal allergy in adolescents were higher than those described in the ISAAC (16.3% and 13%) and similar in schoolchildren to the ISAAC (9% and 9.4%). Conclusions: There has been a stabilisation of rhinitis, rhinoconjunctivitis and nasal allergy in schoolchildren that slows the previous upward trend of ISAAC; and a slight non-significant increase in rhinoconjunctivitis and nasal allergy in adolescents. The variability found in adolescents would require local research to be better understood (AU)

Mediterranean diet in the Castilian plains: Dietary patterns and childhood asthma in 6–7-year-old children from the province of Salamanca

Salamanca is the only Spanish center with no coastal line participating in the Global Asthma Network phase-I study. Questionnaires were collected from 6–7-year-old 2388 children and analyzed in par-ticular for their diet and asthma symptoms as part of this study. The prevalence of current asthma (CA) was 9%, doctor-confirmed asthma (DCA) was 7%, and current severe asthma (CSA) accounted to 2.9%. Two Mediterranean Diet Scores (MDS) were performed to evaluate adherence of these children to the Mediterranean diet. Principal component analysis generated four dietary patterns. The relationship between asthma and each food type, MDS, and dietary patterns was assessed using multivariate adjusted logistic regression. Adherence to the Mediterranean diet by Salamanca’s chil-dren and prevalence of asthma in Salamanca were similar to the findings of coastal located centers of other studies. High punctuation in MDS was associated with high prevalence of asthma. Higher scores for the pattern “Fats and sugar” was associated with less current asthma but not with DCA or CSA. These findings might be due to improvement in the diet of asthma children, reverse causation factor, how the questionnaire collected information about diet, and perhaps the manner in which the scores were constructed. The complexity of interconnections between nutrients, foods, and dietary patterns, and the heterogeneous nature of asthma, makes it difficult to identify single fac-tor that affected its development. Our findings require corroboration by additional studies (AU)

Prevalencia y evolución temporal de síntomas de asma en España. Estudio Global Asthma Network (GAN) / Prevalence and temporal evolution of asthma symptoms in Spain. Global Asthma Network (GAN) study

Introducción: Se desconoce la evolución temporal de la prevalencia de asma descrita en el ISAAC (International Study of Asthma and Allergies in Childhood) en 2002 o si las diferencias geográficas o por edades se mantienen en España. Objetivo: Describir la prevalencia de los síntomas de asma en distintas áreas geográficas españolas y compararla con la de aquellos centros que participaron en el ISAAC. Métodos: Estudio transversal de prevalencia de asma, realizado en 2016-2019 a 19.943 adolescentes de 13-14 años y 17.215 escolares de 6-7 años de seis áreas geográficas españolas (Cartagena, Bilbao, Cantabria, La Coruña, Pamplona y Salamanca). Los síntomas de asma se recogieron mediante un cuestionario escrito y videocuestionario según el protocolo Global Asthma Network (GAN). Resultados: La prevalencia de sibilancias recientes (últimos 12 meses) fue del 15,3% a los 13-14 años y del 10,4% a los 6-7 años, con variaciones en los adolescentes, desde un 19% en Bilbao, hasta un 10,2% en Cartagena; y en los escolares, desde un 11,7% en Cartagena, hasta un 7% en Pamplona. Estas prevalencias fueron superiores a las del ISAAC (10,6% en adolescentes y 9,9% en los escolares). Un 21,3% de adolescentes y un 12,4% de los escolares refirieron asma alguna vez. Conclusiones: Existe una alta prevalencia de síntomas asmáticos con un incremento en los adolescentes y una estabilización en los escolares españoles con respecto al ISAAC. No se aprecian tan claramente variaciones geográficas en la prevalencia de asma, pero las áreas que tenían prevalencias elevadas mantienen cifras altas. (AU)

Introduction: The temporal evolution of the prevalence of asthma described in the International Study of Asthma and Allergies in Childhood (ISAAC) in 2002 is unknown, or if the geographical or age differences are maintained in Spain. Objective: To describe the prevalence of asthma symptoms in different Spanish geographical areas and compare it with that of those centers that participated in the ISAAC. Methods: Cross-sectional study of asthma prevalence, carried out in 2016–2019 with 19,943 adolescents aged 13–14 years and 17,215 schoolchildren aged 6–7 years from six Spanish geographical areas (Cartagena, Bilbao, Cantabria, La Coruña, Pamplona and Salamanca). Asthma symptoms were collected using a written questionnaire and video questionnaire according to the Global Asthma Network (GAN) protocol. Results: The prevalence of recent wheezing (last 12 months) was 15.3% at 13–14 years and 10.4% at 6–7 years, with variations in adolescents, from 19% in Bilbao to 10.2% in Cartagena; and in schoolchildren, from 11.7% in Cartagena to 7% in Pamplona. These prevalences were higher than those of the ISAAC (10.6% in adolescents and 9.9% in schoolchildren). About 21.3% of adolescents and 12.4% of schoolchildren reported asthma at some time. Conclusions: There is a high prevalence of asthmatic symptoms with an increase in adolescents and a stabilization in Spanish schoolchildren with respect to the ISAAC. Geographical variations in asthma prevalence are not so clearly appreciated, but areas with high prevalences maintain high numbers. (AU)

Necesidad de pediatras de Atención Primaria. Plazas de Pediatría en Atención Primaria vacantes y necesidad de formación específica en esta área competencial / Need for Primary Care pediatricians. Pediatric vacancies in primary care and the need for specific training in this area of competence

Introducción: existe un déficit de pediatras en Atención Primaria, denunciado en múltiples ocasiones en los últimos años por las sociedades de Pediatría de Atención Primaria (PAP). El objetivo de este trabajo es conocer las plazas existentes de PAP no cubiertas por pediatras, las plazas que se precisan crear por cupos excesivos y la forma en la que se puede vehiculizar a un mayor número de residentes hacia esas necesidades. Material y métodos: análisis de los datos de plazas con un exceso de cupo (más de 1251 niños/pediatra), en base a los datos del Ministerio de Sanidad (2018), de las plazas no cubiertas por especialistas de Pediatría y de las salidas profesionales de los residentes basados en estudios publicados por la Asociación Española de Pediatría de Atención Primaria (AEPap, 2017-2018). Resultados: existen 1665 plazas no ocupadas por especialistas en Pediatría y 792 que se deberían crear para desdoblar los cupos de más de 1251 niños/pediatra, lo que hacen un total de 2457 plazas. Un 30% de los pediatras que finalizan la especialidad realizan su salida profesional a la Atención Primaria (AP) mientras que esta supone el 60% de las plazas de Pediatría. Durante el periodo de residencia solo en un 6% de la formación tiene lugar en AP. Conclusiones: el objetivo es lograr que todas las plazas de Pediatría existentes y que se precisan crear sean atendidas por pediatras. Es necesario vehiculizar la mayoría de los residentes de Pediatría hacia la AP, a la vez que aumentar el tiempo de rotación por estas unidades (AU)

Introduction: there is a deficit of primary care pediatricians, already reported by primary care pediatric societies in recent years. The objective of this analysis is to know the existing primary care pediatric positions, not covered by pediatricians, the positions that need to be created due to excessive quotas and the way in which a greater number of residents can be channeled to Primary Care.Method: analysis of the data of places with an excess of population assigned (more than 1,251 children/pediatrician), based on data of Health Ministry (2018) and of places not covered by pediatric specialists and of the professional opportunities of residents based on published studies of the Spanish Association of Primary Care Pediatrics (2017-2018).Results: there are 1665 Pediatric places not occupied by pediatricians and 792 that should be created to split the quotas of more than 1251 children/pediatrician, making a total of 2457 places. 30% of pediatric residents who complete their pediatric specialty go on to Primary Care, while 60% of pediatric places are in Primary Care. During the residence period only 6% of the training takes place in primary care.Conclusions: the aim is to ensure that all existing and required primary care pediatric positions are attended by pediatricians. It is necessary to orient the majority of Pediatric residents towards Primary Care, and the rotation time through these units should also be increased. (AU)

La guía española del manejo del asma (GEMA 4.0) está obsoleta en lo que a vacunación antineumocócica se refiere. Respuesta de los autores / Obsolete anti-pneumococcal vaccination recommendations in the spanish guidelines for the management of asthma (GEMA 4.0): the authors reply

No disponible